Intestinal Candidiasis
Intestinal Candidiasis (IC) refers to an overgrowth of the Candida yeast genus in the small and large intestines. Its presence in the gut is normal, but it can be overabundant in certain populations like premature infants and the immunocompromised. Probiotics and antifungal drugs may prevent IC.
Quick Answer
What it is
Intestinal Candidiasis (IC) refers to an overgrowth of the Candida yeast genus in the small and large intestines. Its presence in the gut is normal, but it can be overabundant in certain populations like premature infants and the immunocompromised.
Key findings
No graded findings are available yet.
Safety
No specific caution or interaction language was detected in the current summary/outcome notes.
ℹ️ Quick Facts
Quick Facts: Intestinal Candidiasis
- Supplements Studied:0
Evidence-Based Protocol
Supplement stack ranked by research quality
Primary Stack (Tier 1)
Beneficial yeast that competes with Candida; supports gut barrier function
Restores healthy gut bacteria balance; competes with Candida for colonization
Supporting Stack (Tier 2)
Medium-chain fatty acid with antifungal properties; disrupts Candida cell membranes
Contains carvacrol and thymol with antifungal properties
Allicin has antifungal activity against Candida species
Antimicrobial alkaloid with activity against Candida; also supports blood sugar
How It Works
Intestinal candidiasis refers to overgrowth of Candida yeast in the gut. While Candida is normally present in small amounts, various factors can allow it to overgrow, potentially causing digestive symptoms.
IMPORTANT NOTE:
The concept of 'candida overgrowth syndrome' is controversial in mainstream medicine. True invasive candidiasis is a serious medical condition in immunocompromised patients. Mild yeast imbalance may occur but diagnosis is difficult.
POTENTIAL SYMPTOMS:
RISK FACTORS:
DIETARY APPROACHES:
WHEN TO SEE A DOCTOR:
* Probiotics are foundational for restoring gut balance.
* S. boulardii is a beneficial yeast that competes with Candida.
* Natural antifungals may provide supportive benefit.
Expected timeline: Dietary changes and probiotics may improve symptoms within 2-4 weeks. Persistent symptoms require medical evaluation.